Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Christopher

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|June 25, 2011
Selectivity of kinase inhibitor fragmentsPaul Bamborough, Murray J Brown, John A Christopher, et al.
Current Opinion in Pharmacology|December 3, 2014
Structures of mGluRs shed light on the challenges of drug development of allosteric modulatorsKirstie A Bennett, Andrew S Doré, John A Christopher, et al.
Organic & Biomolecular Chemistry|June 10, 2004
The nucleophilic addition of alpha-metallated 1,3-dioxanes to planar chiral cationic eta3-allylmolybdenum complexes. Synthesis of (2E,5S,6R,7E)-6-methyl-8-phenylocta-2,7-dienoic acid methyl ester, a key component of the CryptophycinsJohn Cooksey, Andrew Gunn, Philip J Kocienski, et al.
The Journal of Organic Chemistry|June 13, 2009
Polysubstituted pyridazinones from sequential nucleophilic substitution reactions of tetrafluoropyridazineGraham Pattison, Graham Sandford, Dmitry S Yufit, et al.
Beilstein Journal of Organic Chemistry|June 22, 2010
9,10-Dioxa-1,2-diaza-anthracene derivatives from tetrafluoropyridazineGraham Pattison, Graham Sandford, Dmitrii S Yufit, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2006
5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinasePaul Bamborough, John A Christopher, Geoffrey J Cutler, et al.
Current Topics in Medicinal Chemistry|August 20, 2009
Progress towards the development of anti-inflammatory inhibitors of IKKbetaPaul Bamborough, James F Callahan, John A Christopher, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2009
1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3John A Christopher, Francis L Atkinson, Benjamin D Bax, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38alpha MAP kinaseKenneth Down, Paul Bamborough, Catherine Alder, et al.
Journal of Medicinal Chemistry|March 23, 2013
Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug designJohn A Christopher, Jason Brown, Andrew S Doré, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|June 25, 2011
Selectivity of kinase inhibitor fragmentsPaul Bamborough, Murray J Brown, John A Christopher, et al.
Current Opinion in Pharmacology|December 3, 2014
Structures of mGluRs shed light on the challenges of drug development of allosteric modulatorsKirstie A Bennett, Andrew S Doré, John A Christopher, et al.
Organic & Biomolecular Chemistry|June 10, 2004
The nucleophilic addition of alpha-metallated 1,3-dioxanes to planar chiral cationic eta3-allylmolybdenum complexes. Synthesis of (2E,5S,6R,7E)-6-methyl-8-phenylocta-2,7-dienoic acid methyl ester, a key component of the CryptophycinsJohn Cooksey, Andrew Gunn, Philip J Kocienski, et al.
The Journal of Organic Chemistry|June 13, 2009
Polysubstituted pyridazinones from sequential nucleophilic substitution reactions of tetrafluoropyridazineGraham Pattison, Graham Sandford, Dmitry S Yufit, et al.
Beilstein Journal of Organic Chemistry|June 22, 2010
9,10-Dioxa-1,2-diaza-anthracene derivatives from tetrafluoropyridazineGraham Pattison, Graham Sandford, Dmitrii S Yufit, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2006
5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinasePaul Bamborough, John A Christopher, Geoffrey J Cutler, et al.
Current Topics in Medicinal Chemistry|August 20, 2009
Progress towards the development of anti-inflammatory inhibitors of IKKbetaPaul Bamborough, James F Callahan, John A Christopher, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2009
1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3John A Christopher, Francis L Atkinson, Benjamin D Bax, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38alpha MAP kinaseKenneth Down, Paul Bamborough, Catherine Alder, et al.
Journal of Medicinal Chemistry|March 23, 2013
Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug designJohn A Christopher, Jason Brown, Andrew S Doré, et al.
Pageof 4